Alvotech Could Upend Expectations For US Humira Biosimilars

Founder And Chairman Robert Wessman Discusses Firm’s Adalimumab Prospects

 
• By David Wallace
  
Robert Wessman Alvogen Alvotech
Robert Wessman discusses in detail Alvotech’s expectations around adalimumab • Source: Alvotech
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products